Expert-Driven Psychiatry Case: LAIs for Schizophrenia - Full Length

In this expert-driven psychiatry case, Christoph Correll, MD reviews three case reports for patients with schizophrenia who may be candidates to switch to long acting injectable (LAI) antipsychotics from oral medication. In this full-length video, he will:

- Introduce the three patients: 2 males, one female who range in age from 21-43
- Share data that highlights patient, clinician, and caregiver response to LAIs
- Share research that highlights the benefits of LAIs
- How to respond to breakthrough psychosis or continued relapse
- The role of LAIs with or without oral medication to avoid further psychosis

- - - - -
Presented by The Journal of Clinical Psychiatry.

Christoph Correll, MD, is professor of psychiatry at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and a medical director of the Recognition and Prevention (RAP) program at Zucker Hillside Hospital.